FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Petition Seeks Removal of Bamboos NarxCare Software

[ Price : $8.95]

The Center for U.S. Policy petitions FDA to deem a widely used clinical decision support software, Bamboo Healths NarxCare, a misb...

Gene Therapy Guide on NonClinical Biodistribution

[ Price : $8.95]

FDA posts an International Council for Harmonization final guidance entitled S12 Nonclinical Biodistribution (BD) Considerations ...

Teva Recalls Fentanyl Lots Over Product Insert

[ Price : $8.95]

Teva Pharmaceuticals recalls 13 lots of various strengths of fentanyl buccal tablets due to safety updates that were omitted in th...

FDA Approves Otsuka/Lundbeck Schizophrenia Drug

[ Price : $8.95]

FDA approves an Otsuka America Pharmaceutical and Lundbeck NDA for Abilify Asimtufii (aripiprazole) a once-every-two-months inject...

ViiV Dovato Ad Claims Challenged

[ Price : $8.95]

The Better Business Bureaus National Advertising Division refers to FDA and the Federal Trade Commission for review and possible e...

Drug Supply Chain Independence Bill

[ Price : $8.95]

Bipartisan legislation is reintroduced in the House that its sponsors say will make the nations pharmaceutical supply chain less d...

Ultromics Gets Breakthrough Status for AI Device

[ Price : $8.95]

FDA grants Ultromics a breakthrough device designation for its artificial intelligence-supported platform for detecting cardiac am...

Cybersecurity Alert on Illumina Device Software

[ Price : $8.95]

FDA issues an alert about a cybersecurity vulnerability affecting the Universal Copy Service software in several Illumina laborato...

FDA Approves Oral Fecal Microbiota Capsules

[ Price : $8.95]

FDA approves a Seres Therapeutics BLA for Vowst (fecal microbiota spores, live-brpk), an orally administered microbiota-based prod...

Prevent Makena Compounding: Public Citizen

[ Price : $8.95]

Public Citizen calls on FDA to promptly add Covis Pharmas Makena to the official list of drugs that have been withdrawn for reason...